UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038019
Receipt number R000043343
Scientific Title Accompaniment study:Effect study of the treatment as usual group of the randomized controlled trial of the cognitive-behavioral therapy for generalized anxiety disorder patients
Date of disclosure of the study information 2019/09/17
Last modified on 2022/06/23 11:52:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Accompaniment study:Effect study of the treatment as usual group of the randomized controlled trial of the cognitive-behavioral therapy for generalized anxiety disorder patients

Acronym

Effect study of the TAU group in RCT of the cognitive-behavioral therapy for generalized anxiety disorder patients

Scientific Title

Accompaniment study:Effect study of the treatment as usual group of the randomized controlled trial of the cognitive-behavioral therapy for generalized anxiety disorder patients

Scientific Title:Acronym

Effect study of the TAU group in RCT of the cognitive-behavioral therapy for generalized anxiety disorder patients

Region

Japan


Condition

Condition

Generalized Anxiety Disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Measurement of effects when applying cognitive behavioral therapy to TAU group

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Penn State Worry Questionnaire (PSWQ)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Cognitive behavioral therapy (5sessions)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Primary diagnosis of Generalized Anxiety Disorder using the Mini- International Neuropsychiatric Interview, DSM-5.
(2) The age between 18 to 65.
(3) Patients with full consent of participation in the study.
(4) Patients' PSWQ score is above 45.
(5) No change of medical drugs during the study.
(6) Possible to understand cognitive behavioral therapy, and has mental and physical condition that can be participate the session for at least one year.
(7) If Generalized Anxiety Disorder is primary diagnosed, patients with Social Anxiety Disorder, Major Depressive Disorder, Agoraphobia will not be excluded from the study.

Key exclusion criteria

psychosis, major depression, bipolar, active suicidality, organic brain disorder, substance abuse or dependence, antisocial personality disorder, other severe mental / physical condition

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Shimizu

Organization

Graduate School of Medicine Chiba University,Chiba University Hospital

Division name

Research Center for Child Mental Development, Department of Cognitive Behavioral Physiology,Cognitive Behavioral Therapy Center

Zip code

2608670

Address

1-8-1 Inohana, Chuouku, Chiba, Japan

TEL

043-226-2027

Email

eiji@faculty.chiba-u.jp


Public contact

Name of contact person

1st name Honami
Middle name
Last name Arai

Organization

Chiba University

Division name

Research Center for Child Mental Development

Zip code

2608670

Address

1-8-1 Inohana, Chuouku, Chiba, Japan

TEL

043-226-2975

Homepage URL


Email

aypa1127@chiba-u.ac.jp


Sponsor or person

Institute

Chiba University Hospital Clinical Research Center

Institute

Department

Personal name



Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University

Address

Clinical Research Center

Tel

043-226-2027

Email

prc-jim@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 09 Month 05 Day

Date of IRB

2019 Year 09 Month 05 Day

Anticipated trial start date

2019 Year 09 Month 20 Day

Last follow-up date

2021 Year 10 Month 11 Day

Date of closure to data entry

2022 Year 02 Month 24 Day

Date trial data considered complete

2022 Year 03 Month 03 Day

Date analysis concluded

2022 Year 03 Month 14 Day


Other

Other related information



Management information

Registered date

2019 Year 09 Month 17 Day

Last modified on

2022 Year 06 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043343